E-cigarettes: Effects in phagocytosis and cytokines response against Mycobacterium tuberculosis.
Nonclinical
Immunotoxicity
In Vitro
Gómez (2020)
In Vitro Systems Toxicology assessment of a Candidate Modified Risk Tobacco Product Shows Reduced Toxicity Compared to That of a Conventional Cigarette
Non-Clinical
Cytotoxicity
In Vitro
Gonzalez (2015)
E-cigarettes as a source of toxic and potentially carcinogenic metals
Non-Clinical
Carcinogenicity
In Vitro
hess (2017)
Identification of Cytotoxic Flavor Chemicals in Top-Selling Electronic Cigarette Refill Fluids
Non-Clinical
Cytotoxicity
In Vitro
hua (2019)
In vitro and in silico genetic toxicity screening of flavor compounds and other ingredients in tobacco products with emphasis on ENDS.
Nonclinical
Genotoxicity
In Vitro
hung (2020)
Risk analysis for the Carcinogen Pulegone in Mint- and Menthol-Flavored e-Cigarettes and Smokeless Tobacco Products.
Nonclinical
Carcinogenicity
In Vitro
Jabba (2019)
a lower impact of an acute exposure to electronic cigarette aerosols than to cigarette smoke in human organotypic buccal and small airway cultures was demonstrated using systems toxicology assessment.
Nonclinical
Respiratory Toxicity
In Vitro
Iskandar (2019)
an inter-laboratory in vitro assessment of cigarettes and next generation nicotine delivery products.
Nonclinical
ALL
In Vitro
Ito (2019)
In vitro long-term repeated exposure and exposure switching of a novel tobacco vapor product in a human organotypic culture of bronchial epithelial cells.
Nonclinical
Respiratory Toxicity
In Vitro
Ito (2020)
Mainstream smoke Constituents and In Vitro toxicity comparative analysis of 3R4F and 1R6F reference cigarettes
Non-Clinical
Respiratory Toxicity
In Vitro
Jaccard et al (2019)